Skip to content

The Oncology Institute, Inc. TOI Free cash flow margin

Free cash flow margin at other companies

McKesson logo
McKessonMCK
1.4%-0.1pp
Immunome logo
ImmunomeIMNM
-5,118.9%-8,601pp
Option Care Health, Inc. logo
Option Care Health, Inc.OPCH
3.8%-2.9pp
BrightSpring Health Services, Inc. logo
BrightSpring Health Services, Inc.BTSG
3%
Exelixis logo
ExelixisEXEL
38.6%+2.9pp
Incyte logo
IncyteINCY
28.2%+19.7pp

Other financials

Income statement

See full
Revenue$147.4M+41.2%
Operating income-$6.5M+34.3%
Net income-$2.5M+87.3%
EPS (diluted)-$0.02+90.5%

Balance sheet

See full
Cash & equivalents$30.3M-23.8%
Total debt$104.9M+2.5%
Total equity-$16.3M-421%
Total assets$168.2M+2.6%

Cash flow

See full
Operating cash flow-$2.2M+55.6%
CapEx$1.0M+218%
Free cash flow-$3.3M+38.7%

Valuation

See full
Market cap$511.91M+133%
Enterprise value$586.58M+108%
P/S0.9×+0.4×

Profitability

See full
Operating margin-6%-2.1pp
Net margin-8%-2.7pp

Returns & leverage

See full
Return on equity-277.6%-700pp
Debt / equity20.2×+17.3×
Current ratio1.5×-0.3×

Where this comes from

Calculated from The Oncology Institute, Inc.’s reported figures.

Based on trailing twelve months.

The official record: The Oncology Institute, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about The Oncology Institute, Inc.'s free cash flow margin.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is The Oncology Institute, Inc.'s free cash flow margin?
The Oncology Institute, Inc. (TOI) reported free cash flow margin of -5.1% in Q1 2026.
What is the long-term trend for The Oncology Institute, Inc.'s free cash flow margin?
Over 4 years (2020 to 2025), The Oncology Institute, Inc.'s free cash flow margin has grown at a 100.9% compound annual growth rate (CAGR), from -0.4% to -6%.
What does free cash flow margin mean?
Free cash flow (operating cash flow minus capital expenditures) as a percentage of revenue, trailing twelve months. Measures how efficiently revenue converts into discretionary cash.